# The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients

> **NCT00164814** · — · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 100 (actual)

## Conditions studied

- Non-Cardiac Chest Pain

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00164814
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** Funding ended
- **Last updated:** 2008-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164814, "The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00164814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*